Phase IV-Cervical Dystonia-INTEREST IN CD2
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Orthopedic, Women's Studies |
| Therapuetic Areas: | Neurology, Orthopedics / Podiatry, Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/9/2019 |
| Start Date: | December 2012 |
| End Date: | September 25, 2017 |
An International Observational Prospective Study On Long-Term Response To Botulinum Toxin Type A (BoNT-A) Injections In Subjects Suffering From Idiopathic Cervical Dystonia (CD) - Pharmaco-Economic Impact
The purpose of the study is to document long-term response in real-life practice after
injection cycles with BoNT-A in subjects suffering from idiopathic cervical dystonia
(Long-term clinical and pharmaco-economic data).
injection cycles with BoNT-A in subjects suffering from idiopathic cervical dystonia
(Long-term clinical and pharmaco-economic data).
Inclusion Criteria:
- Subject for whom there is an intention to treat with BoNT-A.
- BoNT treatment naïve or previously treated with BoNT.
- If previously treated with BoNT, at least a 12-week interval between the last
injection (BoNT-A or BoNT-B) and inclusion.
- Subject able to comply with the protocol.
- Provision of written informed consent prior to collect the data.
Exclusion Criteria:
- Contraindications to any BoNT-A preparations.
- The subject has already been included in the study.
We found this trial at
5
sites
Tufts Medical Center Tufts Medical Center is an internationally-respected academic medical center – a teaching...
Click here to add this to my saved trials
Click here to add this to my saved trials
Vanderbilt University Vanderbilt offers undergraduate programs in the liberal arts and sciences, engineering, music, education...
Click here to add this to my saved trials
Click here to add this to my saved trials